X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4108) 4108
Publication (345) 345
Book Review (18) 18
Book Chapter (17) 17
Conference Proceeding (9) 9
Dissertation (3) 3
Data Set (1) 1
Government Document (1) 1
Magazine Article (1) 1
Newsletter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1587) 1587
index medicus (1564) 1564
humans (1372) 1372
oxazines (1050) 1050
oxazines - chemistry (886) 886
male (880) 880
oxazines - pharmacology (709) 709
female (672) 672
oxazines - metabolism (637) 637
pharmacology & pharmacy (534) 534
benzoxazines (530) 530
analysis (481) 481
rats (471) 471
biochemistry & molecular biology (457) 457
mice (349) 349
fluorescence (326) 326
adult (307) 307
oxazines - analysis (293) 293
neonicotinoids (289) 289
oxazines - therapeutic use (274) 274
dose-response relationship, drug (267) 267
time factors (263) 263
kinetics (262) 262
chemistry, multidisciplinary (251) 251
insecticides (248) 248
chemistry, analytical (247) 247
xanthenes (237) 237
toxicology (224) 224
biochemical research methods (222) 222
chemistry, organic (216) 216
neurosciences (216) 216
in-vitro (213) 213
middle aged (213) 213
coloring agents (209) 209
molecular structure (208) 208
thiamethoxam (202) 202
hiv infections - drug therapy (194) 194
oxazines - administration & dosage (194) 194
chemistry, medicinal (190) 190
oxazines - chemical synthesis (187) 187
cells, cultured (184) 184
research (184) 184
entomology (181) 181
fluorescent dyes - chemistry (178) 178
microbiology (176) 176
oxidation-reduction (172) 172
toxicity (172) 172
fluorescent dyes (170) 170
cell survival - drug effects (166) 166
cell biology (165) 165
article (164) 164
oxazines - toxicity (161) 161
hydrogen-ion concentration (160) 160
infectious diseases (160) 160
environmental sciences (159) 159
staining and labeling (152) 152
derivatives (151) 151
chemistry (147) 147
oxazine (141) 141
oxazines - pharmacokinetics (140) 140
cell line (139) 139
expression (137) 137
spectrometry, fluorescence (137) 137
nile red (136) 136
reproducibility of results (136) 136
cells (135) 135
proteins (135) 135
immunology (134) 134
cell line, tumor (133) 133
rats, sprague-dawley (132) 132
biophysics (129) 129
chemistry, physical (129) 129
biotechnology & applied microbiology (127) 127
enzymes (125) 125
metabolism (124) 124
structure-activity relationship (118) 118
apoptosis (117) 117
models, molecular (117) 117
xanthenes - metabolism (117) 117
catalysis (115) 115
physiological aspects (115) 115
chemical properties (113) 113
in vitro techniques (113) 113
indicators and reagents (112) 112
oxazines - adverse effects (112) 112
lactose - analogs & derivatives (111) 111
methylcellulose - analogs & derivatives (111) 111
sensitivity and specificity (111) 111
nanoparticles (110) 110
aged (109) 109
insecticides - toxicity (109) 109
methods (109) 109
lipids (108) 108
efavirenz (107) 107
cytotoxicity (105) 105
resistance (105) 105
nitro compounds - toxicity (103) 103
research article (103) 103
pesticides (102) 102
chromatography, high pressure liquid (101) 101
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4043) 4043
Japanese (47) 47
German (28) 28
Chinese (17) 17
Russian (17) 17
Italian (8) 8
Spanish (4) 4
French (3) 3
Portuguese (3) 3
Polish (2) 2
Arabic (1) 1
Czech (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature, ISSN 0028-0836, 05/2015, Volume 521, Issue 7550, pp. 74 - 76
Journal Article
Pest Management Science, ISSN 1526-498X, 12/2014, Volume 70, Issue 12, pp. 1780 - 1784
Journal Article
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2013, Volume 63, Issue 1, pp. 96 - 100
We report week 96 results from a phase 3 trial of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (EVG/COBI/FTC/TDF, n = 348) vs... 
HIV | cobicistat | phase 3 randomized trial | safety | efficacy | stribild | INFECTIOUS DISEASES | CO-FORMULATED ELVITEGRAVIR | NON-INFERIORITY TRIAL | PHASE-3 | IMMUNOLOGY | TREATMENT-NAIVE | EFAVIRENZ | LOPINAVIR/RITONAVIR | TENOFOVIR | RITONAVIR | Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Humans | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Male | RNA, Viral - blood | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Thiazoles - adverse effects | Young Adult | Deoxycytidine - therapeutic use | Adenine - adverse effects | HIV-1 - physiology | Quinolones - adverse effects | Adenine - therapeutic use | Quinolones - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | Adenine - administration & dosage | Oxazines - adverse effects | Organophosphonates - administration & dosage | Quinolones - administration & dosage | Oxazines - therapeutic use | Creatinine - blood | Carbamates - adverse effects | HIV Infections - drug therapy | Carbamates - therapeutic use | Deoxycytidine - analogs & derivatives | Drug Combinations
Journal Article
Journal Article